[Form 4] Natera, Inc. Insider Trading Activity

Rhea-AI Filing Summary

An officer of Natera, Inc. who serves as President, Clinical Diagnostics reported multiple equity transactions in December 2025. On 12/12/2025, the officer made a charitable gift of 180 common shares, exercised 8,876 and 13,500 stock options at an exercise price of $9.59 per share, and sold 4,692 shares at an average price of $230.7575 to cover the option exercise price and tax obligations. On 12/15/2025, the officer made an additional charitable gift of 115 shares. After these transactions, the officer directly owns 126,450 common shares and holds 5,125 stock options at $9.59 per share, which are fully exercisable and expire on 04/07/2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moshkevich Solomon

(Last) (First) (Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN TX 78753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CLINICALDIAGNOSTICS

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		G		180(1)	D	$0	108,881	D
Common Stock	12/12/2025		M		8,876	A	$9.59	117,757	D
Common Stock	12/12/2025		S		4,692(2)	D	$230.7575	113,065	D
Common Stock	12/12/2025		M		13,500	A	$9.59	126,565	D
Common Stock	12/15/2025		G		115(1)	D	$0	126,450	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$9.59	12/10/2025		M			22,376(3)	(4)	04/07/2026	Common Stock	22,376	$0	5,125	D

Explanation of Responses:

1. Represents a charitable contribution by the Reporting Person.

2. The sale of these shares was effected in order to cover the exercise price and satisfy tax withholding and remittance obligations in connection with the exercise of expiring options.

3. The options exercised were composed of 13,500 incentive stock options and 8,876 non-qualified stock options.

4. The option shares are fully exercisable.

	/s/ Vincent Fontanilla, Attorney-in-Fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Natera (NTRA) report for its officer in December 2025?

The officer reported a mix of stock option exercises, a share sale, and charitable gifts. On 12/12/2025 the officer exercised options and sold shares, and on 12/12/2025 and 12/15/2025 made charitable contributions of common stock.

How many Natera (NTRA) stock options were exercised and at what price?

The officer exercised a total of 22,376 stock options (13,500 incentive stock options and 8,876 non-qualified stock options), each with an exercise price of $9.59 per share.

How many Natera (NTRA) shares were sold and at what price in this report?

The officer sold 4,692 shares of Natera common stock on 12/12/2025 at an average price of $230.7575 per share to cover the option exercise price and related tax withholding and remittance obligations.

What charitable gifts of Natera (NTRA) stock did the officer make?

The report states that the officer made charitable contributions of Natera common stock totaling two transactions: 180 shares on 12/12/2025 and 115 shares on 12/15/2025, both described as charitable contributions by the reporting person.

How many Natera (NTRA) shares does the officer own after these transactions?

Following the reported transactions, the officer directly owns 126,450 shares of Natera common stock, as shown in the final line of the non-derivative securities table.

What stock options does the Natera (NTRA) officer still hold after exercising options?

After exercising options, the officer holds 5,125 remaining stock options with an exercise price of $9.59 per share. These option shares are fully exercisable and have an expiration date of 04/07/2026.